Benefits Canada Live: Current health-care policies impacting private drug coverage

This webinar discussed the pharmaceutical industry’s efforts during the coronavirus crisis, as well as some key, top-of-mind policy issues for Canadian insurers and their potential impact from the private-payer perspective. Further, this webinar covered the proposed Patented Medicines Pricing Review Board (PMPRB) reforms, the value of Canada’s dual-coverage system and the most recent Private Drug Plan Cost Drivers Report.


Date: Tuesday, May 12, 2020

Cassandra Williamson-Hopp, conference editor, Benefits Canada 

Pamela Fralick, president, Innovative Medicines Canada
Joe Farago, executive director, private payers and investment, Innovative Medicines Canada